N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

C93H102F6N16O11 — CID 155448663

About N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (PubChem CID 155448663) has the molecular formula C93H102F6N16O11 and a molecular weight of 1733.93 g/mol. Its IUPAC name is N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.

Molecular Properties

• Compound Name: N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
• PubChem CID: 155448663
• Molecular Formula: C93H102F6N16O11
• Molecular Weight: 1733.93 g/mol
• Exact Mass: 1732.78
• IUPAC Name: N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
• SMILES: COc1cc2nn(C3CCC(CN(C)C4CCC5(CC4)CC(Cc4cccc6c4n(Cc4ccc7c(c4NCCC4CC8(CCN(CC9CCC(n%10cc%11cc(NC(=O)c%12cccc(C(F)(F)F)n%12)c(OC%12CC%12)cc%11n%10)CC9)CC8)C4)C(=O)N(C4CCC(=O)NC4=O)C7=O)c(=O)n6C4CCC(=O)NC4=O)C5)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
• InChI: InChI=1S/C93H102F6N16O11/c1-109(47-52-12-17-61(18-13-52)112-50-58-39-69(74(125-2)41-67(58)107-112)103-83(118)65-7-4-10-76(101-65)92(94,95)96)60-28-31-90(32-29-60)45-55(46-90)38-56-6-3-9-71-82(56)111(89(124)114(71)72-24-26-78(116)105-85(72)120)49-57-16-23-64-80(88(123)115(87(64)122)73-25-27-79(117)106-86(73)121)81(57)100-35-30-54-43-91(44-54)33-36-110(37-34-91)48-53-14-19-62(20-15-53)113-51-59-40-70(75(42-68(59)108-113)126-63-21-22-63)104-84(119)66-8-5-11-77(102-66)93(97,98)99/h3-11,16,23,39-42,50-55,60-63,72-73,100H,12-15,17-22,24-38,43-49H2,1-2H3,(H,103,118)(H,104,119)(H,105,116,120)(H,106,117,121)
• InChIKey: YIZBZSJHIOAKIJ-UHFFFAOYSA-N
• XLogP: 14.78
• TPSA: 313.24 Ų
• H-Bond Donors: 5
• H-Bond Acceptors: 22
• Rotatable Bonds: 24
• Heavy Atoms: 126
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	1733.93
LogP ≤ 5	14.78
H-Bond Donors ≤ 5	5
H-Bond Acceptors ≤ 10	22

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?

The IUPAC name of N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (CID 155448663) is N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.

What is the SMILES notation for N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?

The canonical SMILES for N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is COc1cc2nn(C3CCC(CN(C)C4CCC5(CC4)CC(Cc4cccc6c4n(Cc4ccc7c(c4NCCC4CC8(CCN(CC9CCC(n%10cc%11cc(NC(=O)c%12cccc(C(F)(F)F)n%12)c(OC%12CC%12)cc%11n%10)CC9)CC8)C4)C(=O)N(C4CCC(=O)NC4=O)C7=O)c(=O)n6C4CCC(=O)NC4=O)C5)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.

What is the InChIKey of N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?

The InChIKey is YIZBZSJHIOAKIJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C93H102F6N16O11/c1-109(47-52-12-17-61(18-13-52)112-50-58-39-69(74(125-2)41-67(58)107-112)103-83(118)65-7-4-10-76(101-65)92(94,95)96)60-28-31-90(32-29-60)45-55(46-90)38-56-6-3-9-71-82(56)111(89(124)114(71)72-24-26-78(116)105-85(72)120)49-57-16-23-64-80(88(123)115(87(64)122)73-25-27-79(117)106-86(73)121)81(57)100-35-30-54-43-91(44-54)33-36-110(37-34-91)48-53-14-19-62(20-15-53)113-51-59-40-70(75(42-68(59)108-113)126-63-21-22-63)104-84(119)66-8-5-11-77(102-66)93(97,98)99/h3-11,16,23,39-42,50-55,60-63,72-73,100H,12-15,17-22,24-38,43-49H2,1-2H3,(H,103,118)(H,104,119)(H,105,116,120)(H,106,117,121).

What are the key properties of N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?

N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide has a molecular weight of 1733.93 g/mol, XLogP of 14.78, 24 rotatable bonds, 5 hydrogen bond donors, and 22 hydrogen bond acceptors.

Where does this data come from?

All data for N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is sourced from PubChem (CID 155448663), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).